Iconovo AB (publ) (ICO.ST)
SEK 4.17
(-2.11%)
SEK 4.17
(-2.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -45.77 Million SEK | -11.28% |
| 2022 | -48.35 Million SEK | -82.5% |
| 2021 | -26.49 Million SEK | -60.68% |
| 2020 | -16.49 Million SEK | -40.06% |
| 2019 | -11.77 Million SEK | -102.35% |
| 2018 | -5.81 Million SEK | -312.29% |
| 2017 | 2.74 Million SEK | -23.99% |
| 2016 | 3.6 Million SEK | 440.46% |
| 2015 | -1.05 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -11.08 Million SEK | -14.7% |
| 2024 Q1 | -10.39 Million SEK | 7.44% |
| 2024 Q2 | -9.66 Million SEK | 7.07% |
| 2023 FY | -53.81 Million SEK | -11.28% |
| 2023 Q4 | -11.23 Million SEK | -12.85% |
| 2023 Q3 | -9.95 Million SEK | 23.93% |
| 2023 Q2 | -13.08 Million SEK | -1.54% |
| 2023 Q1 | -12.88 Million SEK | 22.32% |
| 2022 Q2 | -12.23 Million SEK | -29.29% |
| 2022 FY | -48.35 Million SEK | -82.5% |
| 2022 Q4 | -16.58 Million SEK | -64.6% |
| 2022 Q3 | -10.07 Million SEK | 17.62% |
| 2022 Q1 | -9.46 Million SEK | -8.69% |
| 2021 FY | -26.49 Million SEK | -60.68% |
| 2021 Q3 | -3.89 Million SEK | 40.86% |
| 2021 Q2 | -6.58 Million SEK | 10.09% |
| 2021 Q4 | -8.7 Million SEK | -123.5% |
| 2021 Q1 | -7.32 Million SEK | -102.76% |
| 2020 Q4 | -3.61 Million SEK | -56.8% |
| 2020 Q3 | -2.3 Million SEK | 60.41% |
| 2020 Q2 | -5.81 Million SEK | -16.82% |
| 2020 FY | -16.49 Million SEK | -40.06% |
| 2020 Q1 | -4.98 Million SEK | 30.89% |
| 2019 Q4 | -7.2 Million SEK | -253.99% |
| 2019 Q3 | -2.03 Million SEK | 27.29% |
| 2019 Q2 | -2.8 Million SEK | -1144.78% |
| 2019 Q1 | 268 Thousand SEK | -29.69% |
| 2019 FY | -11.77 Million SEK | -102.35% |
| 2018 Q4 | 381.18 Thousand SEK | 119.34% |
| 2018 Q2 | 219 Thousand SEK | 104.92% |
| 2018 Q1 | -4.44 Million SEK | -175.1% |
| 2018 FY | -5.81 Million SEK | -312.29% |
| 2018 Q3 | -1.97 Million SEK | -1000.0% |
| 2017 Q4 | 5.92 Million SEK | 300.37% |
| 2017 Q3 | -2.95 Million SEK | -341.11% |
| 2017 Q2 | 1.22 Million SEK | 184.44% |
| 2017 FY | 2.74 Million SEK | -23.99% |
| 2017 Q1 | -1.45 Million SEK | 0.0% |
| 2016 FY | 3.6 Million SEK | 440.46% |
| 2015 FY | -1.05 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 40.974% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 115.228% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 115.228% |
| Arcoma AB | 4.66 Million SEK | 1082.334% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 65.303% |
| BICO Group AB (publ) | -618.3 Million SEK | 92.596% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | 216.569% |
| CellaVision AB (publ) | 167.05 Million SEK | 127.403% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 30.571% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | -54.8% |
| C-Rad AB (publ) | 44.24 Million SEK | 203.464% |
| Duearity AB (publ) | -25.76 Million SEK | -77.684% |
| Dignitana AB (publ) | -15.02 Million SEK | -204.65% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 51.712% |
| Getinge AB (publ) | 3.81 Billion SEK | 101.2% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 33.12% |
| Integrum AB (publ) | 6.51 Million SEK | 802.923% |
| Luxbright AB (publ) | -25.8 Million SEK | -77.399% |
| Mentice AB (publ) | -679 Thousand SEK | -6641.791% |
| OssDsign AB (publ) | -91.95 Million SEK | 50.219% |
| Paxman AB (publ) | 12.61 Million SEK | 462.761% |
| Promimic AB (publ) | -9.11 Million SEK | -402.048% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 72.865% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 15.132% |
| ScandiDos AB (publ) | -13.48 Million SEK | -239.515% |
| Sectra AB (publ) | 518.49 Million SEK | 108.829% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 30.162% |
| Senzime AB (publ) | -133.74 Million SEK | 65.773% |
| SpectraCure AB (publ) | -21.35 Million SEK | -114.401% |
| Stille AB | 44.95 Million SEK | 201.835% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 98.725% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | 218.882% |